HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: IFRA's New Fragrance Standards; 'Green Beauty Barometer' Results; More

This article was originally published in The Rose Sheet

Executive Summary

The International Fragrance Association releases the 48th Amendment to its Code of Practice, which includes new standards derived via Quantitative Risk Assessment to minimize dermal-sensitization risks. In other news, market research firms highlight survey results underscoring the influence of "all-natural" marketing and celebrity endorsements on personal-care purchasing habits.

You may also be interested in...



Industry Groups Keeping Eye On Montana’s Fragrance-Disclosure Bill

The International Fragrance Association North America and Personal Care Products Council are monitoring state-level proposals in the US to require full fragrance ingredient disclosure, including a Montana bill that passed committee in February. IFRA NA head Farah Ahmed discusses the group’s related advocacy work.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019610

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel